Tenofovir gel (formulated for rectal use)

3 Resources

Resources

Rectal Microbicides
Microbicide Trials Network
The reasons why rectal microbides are needed, challenges to their development, and the results of clinical trials on their safety and acceptability...
20204 pagesEnglishRead More
Direct Links
Rectal Microbicides
Rectal Microbicides Fact Sheet 2020 (146.29k)
MTN-017
Microbicide Trials Network
Links are provided to information about MTN-017. The first Phase II trial of a rectal microbicide, MTN-017 found that a reduced-glycerin formulation...
2016EnglishRead More
Direct Links
MTN 017
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel
Microbicide Trials Network
The results of a Phase II trial of reduced-glycerin 1% tenofovir gel among men who have sex with men and transgender women, published in Clinical...
20161 pageEnglishRead More
Direct Links
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

This website is made possible by the support of the American People through the United States Agency for International Development (USAID) under the Knowledge SUCCESS (Strengthening Use, Capacity, Collaboration, Exchange, Synthesis, and Sharing) Project. Knowledge SUCCESS is supported by USAID’s Bureau for Global Health, Office of Population and Reproductive Health and led by the Johns Hopkins Center for Communication Programs (CCP) in partnership with Amref Health Africa, The Busara Center for Behavioral Economics (Busara), and FHI 360. The contents of this website are the sole responsibility of CCP. The information provided on this website does not necessarily reflect the views of USAID, the United States Government, or the Johns Hopkins University. Read our full Security, Privacy, and Copyright Policies.